Bailal Hanan, Jebrouni Fadoua, El Ouardani Soufia, Al Jarroudi Ouissam, Brahmi Sami Aziz, Afqir Said
Medical Oncology, Mohammed VI University Hospital, Oujda, MAR.
Medical Oncology, Faculty of Medicine and Pharmacy of Oujda, Mohamed First University, Oujda, MAR.
Cureus. 2024 Dec 28;16(12):e76524. doi: 10.7759/cureus.76524. eCollection 2024 Dec.
Desmoplastic melanoma is a rare and distinct subtype of cutaneous melanoma, it presents diagnostic challenges due to the lack of specific clinical features and overlapping histopathological characteristics with other malignancies, which necessitate careful clinicopathological correlation and advanced immunohistochemical profiling. While surgical excision remains the cornerstone of treatment, advances in precision medicine, particularly immune checkpoint inhibitors, have shown promise in improving outcomes for unresectable and metastatic desmoplastic melanoma. We present a case study involving a 52-year-old woman misdiagnosed with a malignant peripheral nerve sheath tumor and later identified as desmoplastic melanoma through re-evaluation of histopathological and immunohistochemical findings. The patient underwent surgical resection followed by adjuvant radiotherapy and showed favorable locoregional development.
促纤维增生性黑色素瘤是皮肤黑色素瘤中一种罕见且独特的亚型,由于缺乏特异性临床特征以及与其他恶性肿瘤存在重叠的组织病理学特征,其诊断面临挑战,这就需要仔细的临床病理关联以及先进的免疫组化分析。虽然手术切除仍是治疗的基石,但精准医学的进展,尤其是免疫检查点抑制剂,已显示出有望改善不可切除和转移性促纤维增生性黑色素瘤的治疗结果。我们报告了一例病例,一名52岁女性最初被误诊为恶性外周神经鞘瘤,后来通过对组织病理学和免疫组化结果的重新评估确诊为促纤维增生性黑色素瘤。该患者接受了手术切除,随后进行辅助放疗,局部区域病情发展良好。